Patents by Inventor Sanket Jaiprakash Mishra

Sanket Jaiprakash Mishra has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • GRP94 selective inhibitors and uses thereof
    Patent number: 11939291
    Abstract: The present technology provides compounds according to Formula I or Formula III as well as compositions including such compounds useful for the treatment of metastatic cancer and/or glaucoma.
    Type: Grant
    Filed: April 9, 2021
    Date of Patent: March 26, 2024
    Assignees: University of Kansas, University of South Florida
    Inventors: Sanket Jaiprakash Mishra, Brian S. J. Blagg, Chad Anthony Dickey
  • GRP94 SELECTIVE INHIBITORS AND USES THEREOF
    Publication number: 20220024869
    Abstract: The present technology provides compounds according to Formula I or Formula III as well as compositions including such compounds useful for the treatment of metastatic cancer and/or glaucoma.
    Type: Application
    Filed: April 9, 2021
    Publication date: January 27, 2022
    Inventors: Sanket Jaiprakash Mishra, Brian S.J. Blagg, Chad Anthony Dickey
  • Grp94 selective inhibitors and uses thereof
    Patent number: 10975030
    Abstract: The present technology provides compounds according to Formula I or Formula III as well as compositions including such compounds useful for the treatment of metastatic cancer and/or glaucoma.
    Type: Grant
    Filed: October 31, 2017
    Date of Patent: April 13, 2021
    Assignees: University of Kansas, University of South Florida
    Inventors: Sanket Jaiprakash Mishra, Brian S. J. Blagg, Chad Anthony Dickey
  • HSP90B N-terminal isoform-selective inhibitors
    Patent number: 10927076
    Abstract: The present technology provides compounds according to Formula (I) as well as compositions including such compounds useful for the treatment of cancers such as non-small cell lung cancer, bladder cancer, or colon cancer.
    Type: Grant
    Filed: January 12, 2018
    Date of Patent: February 23, 2021
    Assignee: University of Kansas
    Inventors: Brian S. J. Blagg, Caitlin Nicole Kent, Anuj Khandelwal, Sanket Jaiprakash Mishra
  • GRP94 SELECTIVE INHIBITORS AND USES THEREOF
    Publication number: 20200071271
    Abstract: The present technology provides compounds according to Formula I or Formula III as well as compositions including such compounds useful for the treatment of metastatic cancer and/or glaucoma.
    Type: Application
    Filed: October 31, 2017
    Publication date: March 5, 2020
    Inventors: Sanket Jaiprakash MISHRA, Brian S.J. BLAGG, Chad Anthony DICKEY
  • HSP90B N-TERMINAL ISOFORM-SELECTIVE INHIBITORS
    Publication number: 20190337894
    Abstract: The present technology provides compounds according to Formula (I) as well as compositions including such compounds useful for the treatment of cancers such as non-small cell lung cancer, bladder cancer, or colon cancer.
    Type: Application
    Filed: January 12, 2018
    Publication date: November 7, 2019
    Inventors: Brian S.J. Blagg, Caitlin Nicole Kent, Anuj Khandelwal, Sanket Jaiprakash Mishra